IGF1 and metabolic syndrome: From this viewpoint we regard the significant elevation of IGF-1 in a low baseline IGF-1 subgroup as a positive change, which is possibly associated with a reduced risk of developing the metabolic syndrome and with improved insulin sensitivity (19, 22).